Live tape
Top 8, mentions 7d10,071TSLA2,067 mentions▲ +0.05GOOGL1,610 mentions▲ +0.04NVDA1,232 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,105 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

KYMR

NASDAQ

Kymera Therapeutics, Inc.

$116 +1.75% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for KYMR to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $9.6B
52-week range $38 – $119.06
Avg volume 311.6K

as of Jul 17, 2026

KYMR insider trades

SEC Form 4

KYMR has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 29 June 2026.

Date Insider Type Shares Value
29 Jun 2026 Booth Bruce Director Sell 153,300 $16.56M
26 Jun 2026 Booth Bruce Director Sell 467,878 $51.60M
26 Jun 2026 BVF PARTNERS L P/IL Director Sell 1,630,658 $173.67M
25 Jun 2026 Booth Bruce Director Sell 548,321 $65.12M
24 Jun 2026 Booth Bruce Director Sell 134,720 $13.54M
23 Jun 2026 Booth Bruce Director Sell 1,408 $141K
22 Jun 2026 Booth Bruce Director Sell 218,544 $21.52M

KYMR reported financials

SEC EDGAR XBRL SEC EDGAR

KYMR reported revenue of $39.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$311.4M.

Figure Reported Period
Revenue $39.2M 31 Dec 2025 fiscal year
Net income −$311.4M 31 Dec 2025 fiscal year
Diluted EPS −$3.69 31 Dec 2025 fiscal year
Total assets $1.6B 30 Jun 2026 at period end
Total equity $1.5B 30 Jun 2026 at period end

KYMR earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.62 $65M
31 Mar 2026 Q1 2026 −$0.71 $34M
31 Dec 2025 FY 2025 −$3.69 $39M
30 Sep 2025 Q3 2025 −$0.94 $3M
30 Jun 2025 Q2 2025 −$0.95 $11M
31 Mar 2025 Q1 2025 −$0.82 $22M
31 Dec 2024 FY 2024 −$2.98 $47M
30 Sep 2024 Q3 2024 −$0.82 $4M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

KYMR institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a KYMR position for the quarter ended 30 Jun 2026 — a combined $1.1B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 8,657,242 $992.7M
Two Sigma Investments Added +44.8% shares 371,374 $42.6M
Marshall Wace New position 167,517 $19.2M
Citadel Advisors Held (±25%) −5.9% shares 111,555 $12.8M
Man Group Added +43.1% shares 19,085 $2.2M
Fisher Asset Management New position 12,732 $1.5M
AQR Capital Management Trimmed −40.2% shares 9,541 $1.1M
D. E. Shaw & Co. New position 2,800 $321K

KYMR fails-to-deliver

SEC CNS data SEC

On 22 Sep 2026, 1,242 shares of KYMR failed to deliver (about $146K).

Settlement date Shares failed Notional % of shares out
22 Sep 2026 1,242 $146K 0.001%
11 Sep 2026 10,096 $1.2M 0.012%
04 Sep 2026 369 $43K <0.001%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings